Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 1, 2011, Pages 247-253

  Tsimberidou, Apostolia M ^a   Letourneau, Katherine ^a   Fu, Siqing ^a   Hong, David ^a   Naing, Aung ^a   Wheler, Jennifer ^a   Uehara, Cynthia ^a   McRae, Stephen E ^a   Wen, Sijin ^a   Kurzrock, Razelle ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hepatic arterial infusion; Paclitaxel; Phase I trial

Indexed keywords

ANASTROZOLE; BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CARMUSTINE; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EXEMESTANE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HEPARIN; IFOSFAMIDE; IMATINIB; IRINOTECAN; LETROZOLE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; SORAFENIB; TAMOXIFEN; TEGAFUR; THYMOCYTE ANTIBODY; TRASTUZUMAB; UNINDEXED DRUG; VINBLASTINE;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; BONE PAIN; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE SYNDROME; DIARRHEA; DRUG DOSE ESCALATION; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; HUMAN; HYPERTENSION; INFECTION; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG EMBOLISM; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; NIGHT SWEAT; PARESTHESIA; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; THROMBOCYTOPENIA; THYROID CANCER; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE-FREE SURVIVAL; FEMALE; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PACLITAXEL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79959574175     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1482-y     Document Type: Article

References (27)

1. Ragnhammar P, Hafstrom L, Nygren P et al (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40:282-308 (Pubitemid 32588124)
2. Power DG, Healey-Bird BR, Kemeny NE (2008) Regional chemotherapy for liver-limited metastatic colorectal cancer. Clin Colorectal Cancer 7:247-259
3. Khatri VP, Chee KG, Petrelli NJ (2007) Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 16:71-83 (Pubitemid 46880341)
4. Pawlik TM, Choti MA (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11:1057-1077
5. Curley SA, Izzo F, Abdalla E et al (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 23:165-182 (Pubitemid 38221602)
6. Damascelli B, Patelli GL, Lanocita R et al (2003) A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings. AJR Am J Roentgenol 181:253-260 (Pubitemid 36741497)
7. Zhao Y, Wang SM, Zhang J (2002) Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion. Ai Zheng 21:1365-1367
8. Chino Y, Suzuki Y, Ubukata N et al (2001) Hepatic infusion of docetaxel using PEIT for a patient with stage IV breast cancer. Gan To Kagaku Ryoho 28:1897-1899
9. Iwamoto S, Gon G, Nohara T et al (2002) A case of liver metastasis of breast cancer successfully treated with paclitaxel infusion into the hepatic artery: an attempt of once weekly regimen. Gan To Kagaku Ryoho 29:917-920
10. Kim SJ, Maeura Y, Ueda N et al (1999) A case of hepatic arterial infusion chemotherapy with docetaxel for liver metastasis from breast cancer. Gan To Kagaku Ryoho 26:1959-1962
11. Kitagawa Y, Nakase Y, Ebihara Y et al (2001) A case of multiple liver metastases from breast cancer successfully treated with intra-arterial administration of paclitaxel. Gan To Kagaku Ryoho 28:2061-2064
12. Yoon CJ, Chung JW, Park JH et al (2003) Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor. Radiology 229:126-131 (Pubitemid 37152114)
13. Matsui S, Tono T, Iwazawa T et al (2002) A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel. Gan To Kagaku Ryoho 29:2076-2079
14. Walton GD, Schreeder MT, Rizzo J et al (1999) Hepatic artery administration of paclitaxel. Cancer Invest 17:118-120 (Pubitemid 29115644)
15. Camacho LH, Kurzrock R, Cheung A et al (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109:2190-2196 (Pubitemid 46801547)
16. http://ctep.cancer.gov/
17. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada. J Natl Cancer Inst 92:205-216
18. Ratain MJ, Eisen T, Stadler WM et al (2006) Phase II placebocontrolled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 24:2505-2512 (Pubitemid 46630627)
19. Kemeny NE, Ron IG (1999) Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 26:524-535 (Pubitemid 29483277)
20. Oura S, Sakurai T, Yoshimura G et al (1998) Recurrent squamous-cell lung cancer treated with bronchial-arterial infusion of docetaxel-case report. Gan To Kagaku Ryoho 25:2109-2113
21. Akisada T, Harada T, Takemoto T et al (2002) A case of advanced hypopharyngeal carcinoma successfully treated with superselective intra-arterial infusion of docetaxel. Gan To Kagaku Ryoho 29:323-328
22. Yabuuchi H, Kuroiwa T, Tajima T et al (2003) Efficacy of intra-arterial infusion therapy using a combination of cisplatin and docetaxel for recurrent head and neck cancers compared with cisplatin alone. Clin Oncol (R Coll Radiol) 15:467-472 (Pubitemid 37455743)
23. Tsimberidou AM, Fu S, Ng C et al (2010) A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver. Cancer [Epub ahead of print]
24. Tsimberidou AM, Moulder S, Fu S et al (2010) Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. Cancer Chemother Pharmacol [Epub ahead of print]
25. Tono T, Iwazawa T, Matsui S et al (2004) Hepatic arterial infusion of paclitaxel for liver metastasis from gastric cancer. Cancer Invest 22:550-554 (Pubitemid 39506876)
26. NCT00732836 A phase 1, open label, non-randomized trial of hepatic arterial infusion of Abraxane with a pharmacokinetic study in advanced solid cancer patients with predominant hepatic metastases, http://clinicaltrials.gov/ ct2/show/NCT00732836? term=kurzrock?abraxane&rank=2
27. NCT01057264 A phase 1, open label, non-randomized trial of hepatic arterial infusion (HAI) of abraxane in combination with gemcitabine and bevacizumab for patients with advanced cancers metastatic to the liver, http://clinicaltrials.gov/ct2/show/NCT01057264?term=tsimberidou&rank=7